CIBEMTOR

Serial Number 88100628
606

Registration Progress

Application Filed
Aug 31, 2018
Under Examination
Mar 19, 2019
Approved for Publication
Jan 22, 2019
Published for Opposition
Jan 22, 2019
Registered

Trademark Image

CIBEMTOR

Basic Information

Serial Number
88100628
Filing Date
August 31, 2018
Published for Opposition
January 22, 2019
Abandonment Date
April 25, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 25, 2022
Classes
005

Rights Holder

Bioverativ Therapeutics Inc.

03
Address
225 Second Avenue
Waltham, MA 02451

Ownership History

Bioverativ Therapeutics Inc.

Original Applicant
03
Waltham, MA

Bioverativ Therapeutics Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Apr 25, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 25, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 3, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 28, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 28, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 23, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 21, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 21, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 21, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 31, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 29, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 27, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 25, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 25, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 10, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 10, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 5, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 3, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 19, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 22, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 14, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 10, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 4, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cold agglutinin disease and chronic immune thrombocytopenia
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005